| 000 | 01097 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513085906.0 | ||
| 264 | 0 | _c19960523 | |
| 008 | 199605s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.312.7033.778a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLesna, M | |
| 245 | 0 | 0 |
_aRisk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cMar 1996 |
||
| 300 |
_a778 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCefotaxime _xadverse effects |
| 650 | 0 | 4 |
_aCephalosporins _xadverse effects |
| 650 | 0 | 4 |
_aDiarrhea _xmicrobiology |
| 650 | 0 | 4 |
_aEnterocolitis, Pseudomembranous _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aParham, D M | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 312 _gno. 7033 _gp. 778 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.312.7033.778a _zAvailable from publisher's website |
| 999 |
_c8604536 _d8604536 |
||